Literature DB >> 8582970

Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene.

J Mickle1, A Milunsky, J A Amos, R D Oates.   

Abstract

A total of 21 infertile men with congenital unilateral absence of the vas deferens (CUAVD) were studied to determine if this disorder involves mutations in the cystic fibrosis (CF) gene. This hypothesis derives from previous work which has established the genetic commonality of CF and congenital bilateral absence of the vas deferens (CBAVD). Both CF and CBAVD may result from compound heterozygosity for CF mutations. In our patients with unilateral vasal aplasia, 12 had anatomically complete and patent vasa deferentia on the contralateral side, i.e. side of the scrotally palpable vas. No CF mutations were detected in this subgroup. The remaining nine patients had a non-iatrogenic occlusion of the contralateral vas at either the inguinal or pelvic level. In this subgroup, eight out of nine (89%) had a mutation detected in one of their two CF genes. This is the first study to define accurately the clinically and anatomically heterogeneous nature of CUAVD and to begin to clarify the genetic basis of unilateral absence of the vas deferens.

Entities:  

Mesh:

Year:  1995        PMID: 8582970     DOI: 10.1093/oxfordjournals.humrep.a136164

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Disorders of ejaculation.

Authors:  W F Hendry
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

Review 2.  The cystic fibrosis transmembrane regulator gene and male infertility.

Authors:  C Quinzii; C Castellani
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

3.  Cystic dysplasia of the epididymis: a disorder of mesonephric differentiation associated with renal maldevelopment.

Authors:  Manuel Nistal; Pilar González-Peramato; Grevelyn Sousa; Miguel Angel García-Cabezas; José Ignacio Rodríguez; Mariana M Cajaiba
Journal:  Virchows Arch       Date:  2010-04-02       Impact factor: 4.064

4.  Identification of the second CFTR mutation in patients with congenital bilateral absence of vas deferens undergoing ART protocols.

Authors:  Rossella Giuliani; Ivana Antonucci; Isabella Torrente; Paola Grammatico; Giandomenico Palka; Liborio Stuppia
Journal:  Asian J Androl       Date:  2010-07-26       Impact factor: 3.285

5.  R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series.

Authors:  Seiichi Villalona; Guillermo Glover-López; Juan Antonio Ortega-García; Rosa Moya-Quiles; Pedro Mondejar-López; Maria C Martínez-Romero; Mariano Rigabert-Montiel; María D Pastor-Vivero; Manuel Sánchez-Solís
Journal:  J Med Case Rep       Date:  2017-02-15

6.  Congenital unilateral absence of the vas deferens with ipsilateral renal agenesis encountered during laparoscopic totally extraperitoneal inguinal hernia repair in an adult patient: A case report.

Authors:  Karel M Smeyers; Kor H Hutting
Journal:  Ann Med Surg (Lond)       Date:  2021-05-27

7.  CFTR gene variants in Indian congenital bilateral absence of vas deferens & its relevance in genetic counselling.

Authors:  Ashutosh Halder; Deepak Pandey
Journal:  Indian J Med Res       Date:  2020-12       Impact factor: 2.375

Review 8.  The epidemiology and etiology of azoospermia.

Authors:  Marcello Cocuzza; Conrado Alvarenga; Rodrigo Pagani
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

9.  Embryology of the Absent Vas Supported by 2 Cases of Congenital Unilateral Absence of Vas With Varied Associations.

Authors:  Gregory Shepherd; Ashok Rajimwale
Journal:  Urol Case Rep       Date:  2014-01-23

10.  Unilateral absence of vas deferens: prevalence among 23.013 men seeking vasectomy.

Authors:  Sarah Miller; Sophie Couture; Gareth James; Simon Plourde; Jacky Rioux; Michel Labrecque
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.